Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 209

Results For "CTO"

4898 News Found

Sun Pharma and Moebius Medical present Phase 2b study on MM-II
Clinical Trials | June 15, 2024

Sun Pharma and Moebius Medical present Phase 2b study on MM-II

There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis


USFDA approves expanded age indication for GSK’s RSV vaccine ‘Arexvy’
Clinical Trials | June 14, 2024

USFDA approves expanded age indication for GSK’s RSV vaccine ‘Arexvy’

Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes


AxoSim appoints Alif Saleh as CEO
People | June 14, 2024

AxoSim appoints Alif Saleh as CEO

Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer


Suven to acquire a majority stake in CDMO player ‘Sapala Organics’
News | June 14, 2024

Suven to acquire a majority stake in CDMO player ‘Sapala Organics’

Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies


IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol
Drug Approval | June 12, 2024

IOL Chemicals receives EDQM CEP certificate for Pantoprazole Sodium Sesquihydrate and Allopurinol

EDQM has also issued a Certificate of Suitability for Allopurino


Schneider Electric launches EcoStruxure for life science segment
Sustainability | June 11, 2024

Schneider Electric launches EcoStruxure for life science segment

Accelerating sustainability in Indian pharma industry


Fischer Medical Venture and BluSim Tech partner to redefine elderly care
Healthcare | June 10, 2024

Fischer Medical Venture and BluSim Tech partner to redefine elderly care

his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio


Neuland unveils refreshed brand identity
News | June 10, 2024

Neuland unveils refreshed brand identity

The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress


Lilly CFO Anat Ashkenazi resigns
People | June 09, 2024

Lilly CFO Anat Ashkenazi resigns

Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024